While FDA-guidelines are critical for understanding GLP-1 eligibility, there are a number of other factors to consider for determining GLP-1 eligibility
It is used in laboratory and preclinical models to study integrated control of body weight, glucose homeostasis and whole-body energy balance, without implying any therapeutic or clinical use
3 Start losing weight Get your treatment plan, prescriptions (if appropriate), and ongoing support from your provider and dietitian, all covered by your insurance
Some metabolic improvements observed during treatment may also shift back toward baseline over time, although this is also dependent on dietary and lifestyle behaviours
Not as a prescription drug
Retatrutide may potentially offer advantages for: Individuals seeking maximum weight loss results